Genetic Tests Suggest STAP Stem Cells ‘Never Existed’
By David Cyranoski,
Nature News Blog
| 06. 03. 2014
Untitled Document
Reports of a new kind of stem cell, produced by simply stressing mature mouse cells, kicked up a storm of controversy soon after their publication in Nature on 30 January. Duplicated and manipulated images as well as plagiarism were found in the two papers, which led to a verdict of misconduct for the lead author, Haruko Obokata of the RIKEN Center for Developmental Biology in Kobe, Japan. There have also been calls for a retraction (which, for at least one of the papers, looks increasingly likely). But the controversy has left open a key question: does the phenomenon, known as stimulus-triggered acquisition of pluripotency, or STAP, exist?
The answer, according to Japanese media reports today on the results of genetic tests on the cells used in the STAP experiments, is no.
STAP cells were claimed to be made by exposing bodily cells to acid or subjecting them to physical pressure. These cells take on characteristics of embryonic stem cells. If further manipulated, they will also form self-renewing stem cell lines, called STAP stem cells, which share most...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...